The GLG Pharma STAT Blog
STAT 3 publications are numerous and we hope that the following links will help you better understand it's importance in cancer cell metabolism and cancer cell death. Inhibiting STAT 3 is an important mechanism for encouraging cancer cell death. Using STAT 3 inhibitors with other traditional cancer chemotherapy should help improve patient outcomes. Linking a diagnostic with a STAT 3 inhibitor will also help reduce patient side effects as well as potentially improve patient outcomes.
Latest Posts
Browse by Tag
- accredited investor (2)
- accredited investors (2)
- Alpha-1 (5)
- Alpha-1 Antitry (2)
- Alpha-1 Antitrypsin deficiency (1)
- angel investor (2)
- angel investors (2)
- Cancer (8)
- cancer diagnosis (6)
- cancer prevention (3)
- Cancer Stem Cells (3)
- Cancer Therapy (3)
- Chemotherapy (2)
- GLG (2)
- GLG Pharma (13)
- jobs act (1)
- PKD (2)
- Polycystic Kidney Disease (3)
- Rare Disease (1)
- Rare Diseases (3)
- sec (1)
- STAT (6)
- STAT 3 inhibitors (6)
- STAT3 (15)
- STAT3 cancer (7)
- STAT3 inhibitors (11)
- STAT3 mechanism (1)
- WIIFM (1)